Atlas Trials

A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.

Clinical trial NCT01785992 · COMPLETED

Trial details

NCT number
NCT01785992
Sponsor
Imperial College London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Breast CancerMetastatic Breast Cancer
Start date
2012-10-01
Primary completion
2014-12-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.